Search

Your search keyword '"Pantep Angchaisuksiri"' showing total 132 results

Search Constraints

Start Over You searched for: Author "Pantep Angchaisuksiri" Remove constraint Author: "Pantep Angchaisuksiri"
132 results on '"Pantep Angchaisuksiri"'

Search Results

1. Low incidence of deep vein thrombosis in critically ill medical patients in Thais: a prospective study

2. Venous thromboembolism prophylaxis in Asian patients with severe COVID-19: A prospective cohort study

3. Incidence of anti-platelet factor4/polyanionic antibodies, thrombocytopenia, and thrombosis after COVID-19 vaccination with ChAdOx1 nCoV-19 in Thais

4. Rhythm versus rate control in patients with newly diagnosed atrial fibrillation – Observations from the GARFIELD-AF registry

5. Practices and challenges for hemophilia management under resource constraints in Thailand

6. Country and health expenditure are major predictors of withholding anticoagulation in atrial fibrillation patients at high risk of stroke

7. On-treatment Comparative Effectiveness of Vitamin K Antagonists and Direct Oral Anticoagulants in GARFIELD-VTE, and Focus on Cancer and Renal Disease

8. Effectiveness and Safety of Direct Oral Anticoagulants in Thai Patients with Atrial Fibrillation: A Real-World Retrospective Cohort Study

9. Association of body mass index with outcomes in patients with newly diagnosed atrial fibrillation: GARFIELD-AF

10. Provoked versus unprovoked venous thromboembolism: Findings from GARFIELD‐VTE

11. Left ventricular thrombus and pulmonary embolism: A case series of thrombosis in COVID‐19 in Thai patients

12. Good recovery of immunization stress-related responses presenting as a cluster of stroke-like events following CoronaVac and ChAdOx1 vaccinations.

13. Vaccine‐induced immune thrombotic thrombocytopenia with ChAdOx1 nCoV‐19 is rare in Asia

14. Prevalence of anti–platelet factor 4/polyanionic antibodies after COVID‐19 vaccination with ChAdOx1 nCoV‐19 and CoronaVac in Thais

15. A quality‐of‐life questionnaire for heavy menstrual bleeding in Thai women receiving oral antithrombotics: Assessment of the translated Menstrual Bleeding Questionnaire

16. Treatment outcome and prognostic factors in PCNSL

17. Cytogenetics and FLT3-ITD mutation predict clinical outcomes in non transplant patients with acute myeloid leukemia

18. Pregnancy-Associated Venous Thromboembolism: Insights from GARFIELD-VTE

19. Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry

20. Management and 1‐Year Outcomes of Patients With Newly Diagnosed Atrial Fibrillation and Chronic Kidney Disease: Results From the Prospective GARFIELD‐AF Registry

21. Correction to: Incidence of thromboembolism in patients with COVID-19: a systematic review and meta-analysis

22. Quality of Vitamin K Antagonist Control and 1-Year Outcomes in Patients with Atrial Fibrillation: A Global Perspective from the GARFIELD-AF Registry.

23. Critical appraisal of the role of recombinant activated factor VII in the treatment of hemophilia patients with inhibitors

24. 36-month clinical outcomes of patients with venous thromboembolism

25. Validating lactate dehydrogenase (LDH) as a component of the PLASMIC predictive tool (PLASMIC-LDH)

26. Thrombosis and anticoagulation: clinical issues of special importance to hematologists who practice in Asia

27. GARFIELD-AF: risk profiles, treatment patterns and 2-year outcomes in patients with atrial fibrillation in Germany, Austria and Switzerland (DACH) compared to 32 countries in other regions worldwide

28. Long-Term Durable FVIII Expression with Improvements in Bleeding Rates Following AAV-Mediated FVIII Gene Transfer for Hemophilia A: Multiyear Follow-up on the Phase I/II Trial of SPK-8011

29. Influence of body mass index on clinical outcomes in venous thromboembolism: Insights from GARFIELD‐VTE

30. Awareness of venous thromboembolism among patients with cancer: Preliminary findings from a global initiative for World Thrombosis Day

31. American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19

32. American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis for patients with COVID-19

33. Eltrombopag in patients with chronic immune thrombocytopenia in Asia-Pacific, Middle East, and Turkey: final analysis of CITE

34. Pregnancy-Associated Venous Thromboembolism: Insights from GARFIELD-VTE

35. Development and implementation of common data elements for venous thromboembolism research: on behalf of SSC Subcommittee on official Communication from the SSC of the ISTH

36. Good recovery of immunization stress-related responses presenting as cluster of stroke-like events following CoronaVac and ChAdOx1 vaccinations

37. Determination of von Willebrand factor level in patient with sickle cell diseasein vaso‐occlusive crisis

38. A proposal for staging COVID‐19 coagulopathy

39. Maternal death and postpartum hemorrhage in sub‐Saharan Africa – A pilot study in metropolitan Mozambique

40. 2022 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, including patients with COVID-19

41. Management strategies and clinical outcomes in patients with inferior vena cava thrombosis: Data from GARFIELD-VTE

42. 36-Month Clinical Outcomes of Patients with Venous Thromboembolism: GARFIELD-VTE

43. Long-term efficacy and safety of subcutaneous concizumab prophylaxis in hemophilia A and hemophilia A/B with inhibitors

44. Association of body mass index with outcomes in patients with newly diagnosed atrial fibrillation: GARFIELD-AF

45. American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: July 2021 update on post-discharge thromboprophylaxis

46. American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: May 2021 update on the use of intermediate intensity anticoagulation in critically ill patients

47. Prevalence of anti-platelet factor4/polyanionic antibodies after COVID-19 vaccination with ChAdOx1 nCoV-19 and CoronaVac in Thais

49. Provoked versus unprovoked venous thromboembolism: Findings from GARFIELD-VTE

50. Venous thromboembolism in Asia and worldwide: Emerging insights from GARFIELD-VTE

Catalog

Books, media, physical & digital resources